Inventor · disambiguated record
Kevin Chen
Also filed as: CHEN KEVIN · CHEN KEVIN K · CHEN KEVIN KEQIN
16 granted patents·21 pending applications·63 citations·filing 1998–2025
92Inventor score
Files withICELL GENE THERAPEUTICS LLC11RB HEALTH US LLC6DU PONT4iCell Gene Therapeuticics LLC4ICELL GENE THERAPEUTICS INC3
Top patents by PatentIndex Score
37 records- 0192US10273280B2Chimeric antigen receptors (CARs), targeting hematologic malignancies, compositions and methods of use thereofICELL GENE THERAPEUTICS LLC·Filed 2016·Granted Apr 30, 2019·18 cites·20 claims
- 0290US11820819B2Chimeric antigen receptors (CARs), compositions and methods thereofICELL GENE THERAPEUTICS LLC·Filed 2017·Granted Nov 21, 2023·5 cites·5 claims
- 0389US11655452B2Chimeric antigen receptors (CARs), compositions and methods of use thereofICELL GENE THERAPEUTICS LLC·Filed 2016·Granted May 23, 2023·6 cites·4 claims
- 0489US11173179B2Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereofICELL GENE THERAPEUTICS LLC·Filed 2018·Granted Nov 16, 2021·6 cites·1 claims
- 0587US11905528B2Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereofICELL GENE THERAPEUTICS LLC·Filed 2018·Granted Feb 20, 2024·3 cites·7 claims
- 0682US12275787B2Chimeric antigen receptors (CARs), compositions and methods thereofICELL GENE THERAPEUTICS LLC·Filed 2018·Granted Apr 15, 2025·2 cites·2 claims
- 0779US11466075B2Yeast-based immunotherapy against clostridium difficile infectionFENG HANPING·Filed 2016·Granted Oct 11, 2022·2 cites·12 claims
- 0879US2024141041A1CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOFICELL GENE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0978US11278506B2Pharmaceutical formulationRB HEALTH US LLC·Filed 2016·Granted Mar 22, 2022·2 cites·6 claims
- 1075US2023340113A1CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOFICELL GENE THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 1174US12384833B2Yeast-based immunotherapy against Clostridium difficile infectionFENG HANPING·Filed 2022·Granted Aug 12, 2025·0 cites·12 claims
- 1273US2024124547A1CHIMERIC ANTIGEN RECEPTORS (CARs) TARGETING HEMATOLOGIC MALIGNANCIES, COMPOSITIONS AND METHODS OF USE THEREOFiCell Gene Therapeuticics LLC·Filed 2023·Application pending·0 cites
- 1372US2025002550A1Compound chimeric antigen receptor (ccar) targeting multiple antigens, compositions and methods of use thereofICELL GENE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1472US2024041777A1Pharmaceutical capsule containing at least two tabletsRB HEALTH US LLC·Filed 2023·Application pending·0 cites
- 1568US12370189B2Pharmaceutical formulationRB HEALTH US LLC·Filed 2021·Granted Jul 29, 2025·0 cites·8 claims
- 1668US11135238B2Methods to stabilize and reverse atherosclerotic lesions by sulfated polysaccharidesMORNINGBELL WELLNESS LLC·Filed 2018·Granted Oct 5, 2021·2 cites·20 claims
- 1767US12257218B2Pharmaceutical formulationRB HEALTH US LLC·Filed 2022·Granted Mar 25, 2025·0 cites·8 claims
- 1865US2025073258A1Compositions and Methods to Protect and Enhance Structural and Functional Integrity of the Intestinal GlycocalyxCALROY HEALTH SCIENCES LLC·Filed 2024·Application pending·0 cites
- 1964US2024059754A1Chimeric antigen receptors and enhancement of anti-tumor activityiCell Gene Therapeutjics LLC·Filed 2022·Application pending·0 cites
- 2061US2020283534A1CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOFiCell Gene Therapeuticics LLC·Filed 2016·Application pending·0 cites
- 2161US2025235445A1Novel pharmaceutical formulationRB HEALTH US LLC·Filed 2025·Application pending·0 cites
- 2260US2020261373A1Pharmaceutical capsule containing at least two tabletsRECKITT BENCKISER LLC·Filed 2020·Application pending·0 cites
- 2359US6235882B1Gene encoding a putative efflux protein for solvents/antibiotics in pseudomonas mendocinaDU PONT·Filed 1999·Granted May 22, 2001·8 cites·2 claims
- 2458US2025319050A1Pharmaceutical formulationRB HEALTH US LLC·Filed 2025·Application pending·0 cites
- 2558US2022348633A1COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHOD OF USE THEREOFICELL GENE THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 2655US2022241327A1Chimeric Antigen Receptor (CAR) Targeting Multiple Antigens, Compositions and Methods of Use ThereofICELL GENE THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 2755US2019345217A1CHIMERIC ANTIGEN RECEPTORS (CARs) TARGETING HEMATOLOGIC MALIGNANCIES, COMPOSITIONS AND METHODS OF USE THEREOFiCell Gene Therapeuticics LLC·Filed 2019·Application pending·0 cites
- 2853US2017304296A1Novel pharmaceutical formulationRECKITT BENCKISER LLC·Filed 2015·Application pending·0 cites
- 2953US2024261401A1Engineered immune cells, compositions and methods thereofICELL GENE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3053US2017304210A1Pharmaceutical capsule containing at least two tabletsRECKITT BENCKISER LLC·Filed 2015·Application pending·0 cites
- 3152US2021338729A1CHIMERIC ANTIGEN RECEPTORS (CARs) COMPOSITIONS AND METHODS OF USE THEREOFICELL GENE THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 3249US2018371052A1Chimeric antigen receptors and enhancement of anti-tumor activityICELL GENE THERAPEUTICS LLC·Filed 2016·Application pending·0 cites
- 3348US2022331353A1Synergistic compositions and methods to increase vascular nitric oxide to treat endothelial dysfunction and related conditionsCALROY HEALTH SCIENCES LLC·Filed 2022·Application pending·0 cites
- 3446US6225089B1Gene encoding a putative efflux protein for solvents/antibiotics in pseudomonas mendocinaDU PONT·Filed 1999·Granted May 1, 2001·3 cites·9 claims
- 3545US2019135894A1COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHODS OF USE THEREOFiCell Gene Therapeuticics LLC·Filed 2018·Application pending·0 cites
- 3640US6830899B1Method for the production of para-hydroxybenzoate in Pseudomonas mendocinaDU PONT·Filed 1998·Granted Dec 14, 2004·6 cites·22 claims
- 3734US6410265B1Gene encoding a putive efflux protein for solvents/antibiotics in Pseudomonas mendocinaDU PONT·Filed 1998·Granted Jun 25, 2002·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Kevin Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →